Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D<sub>3</sub> and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Mikio Kamimura; Shigeharu Uchiyama; Yukio Nakamura; Shota Ikegami; Keijiro Mukaiyama; Hiroyuki Kato

doi:10.2147/TCRM.S120749

open access to scientific and medical research

Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Original Research

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D₃ and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Total article views		HTML views	PDF downloads	Totals
11,512	Dovepress*	11,058+	1,688	12,746
	PubMed Central*	454	171	625
	Totals	11,512	1,859	13,371
*Since 13 February 2017

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D₃ and alters values of parathyroid hormone, pentosidine, and bone metabolic markers